Clinical trial
Study on Mannan Binding Lectin (MBL) Substitution in MBL-Deficient Children With…
NCT00138736 · Prothya Biosolutions, Industry · Completed
Key facts
| NCT number | NCT00138736 |
|---|---|
| Title | Study on Mannan Binding Lectin (MBL) Substitution in MBL-Deficient Children With Chemotherapy-Induced Neutropenia |
| Official title | Phase II Study on Mannan Binding Lectin (MBL) Substitution in MBL-Deficient Children With Chemotherapy-Induced Neutropenia |
| Lead sponsor | Prothya Biosolutions, Industry |
| Collaborators | Landsteiner Foundation for Blood Transfusion |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | MBL-Deficient, Neutropenia |
| Intervention type | Drug |
| Interventions | Mannan Binding Lectin (MBL), Mannan Binding Lectin |
| Enrollment | 12 |
| Start date | Apr 1, 2004 |
| Completion | Oct 1, 2006 |
| First posted | Aug 30, 2005 |
| Last update posted | Aug 30, 2007 |
| Countries | Netherlands |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: